149 related articles for article (PubMed ID: 22247807)
1. Long-term recurrence-free survival in a patient with stage IVB uterine carcinosarcoma.
Yoon G; Kim YS; Kim BG; Bae DS; Lee JW
J Gynecol Oncol; 2011 Dec; 22(4):292-4. PubMed ID: 22247807
[TBL] [Abstract][Full Text] [Related]
2. Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.
Krivak TC; Seidman JD; McBroom JW; MacKoul PJ; Aye LM; Rose GS
Gynecol Oncol; 2001 Oct; 83(1):89-94. PubMed ID: 11585418
[TBL] [Abstract][Full Text] [Related]
3. Carcinosarcoma of the uterine cervix: case report and discussion.
Laterza R; Seveso A; Zefiro F; Formenti G; Mellana L; Donadello N; Ghezzi F; Bolis P; Riva C
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S98-100. PubMed ID: 17727926
[TBL] [Abstract][Full Text] [Related]
4. Multimodality adjuvant therapy and survival outcomes in stage I-IV uterine carcinosarcoma.
McEachron J; Heyman T; Shanahan L; Tran V; Friedman M; Gorelick C; Economos K; Singhal PK; Lee YC; Kanis MJ
Int J Gynecol Cancer; 2020 Jul; 30(7):1012-1017. PubMed ID: 32447295
[TBL] [Abstract][Full Text] [Related]
5. Cure of metastatic uterine carcinosarcoma to lungs: a case report.
Shamseddine A; Taher A; Abou-Mourad Y; Seoud M; Khalil A
Int J Gynecol Cancer; 2003; 13(1):88-9. PubMed ID: 12631227
[TBL] [Abstract][Full Text] [Related]
6. Carcinosarcoma of the uterus-a single institution retrospective analysis of the management and outcome and a brief review of literature.
Anupama R; Kuriakose S; Vijaykumar DK; Pavithran K; Jojo A; Indu RN; Sheejamol VS
Indian J Surg Oncol; 2013 Sep; 4(3):222-8. PubMed ID: 24426726
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group study.
Sutton G; Kauderer J; Carson LF; Lentz SS; Whitney CW; Gallion H;
Gynecol Oncol; 2005 Mar; 96(3):630-4. PubMed ID: 15721404
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma.
Galaal K; Godfrey K; Naik R; Kucukmetin A; Bryant A
Cochrane Database Syst Rev; 2011 Jan; (1):CD006812. PubMed ID: 21249682
[TBL] [Abstract][Full Text] [Related]
9. A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus.
Wolfson AH; Brady MF; Rocereto T; Mannel RS; Lee YC; Futoran RJ; Cohn DE; Ioffe OB
Gynecol Oncol; 2007 Nov; 107(2):177-85. PubMed ID: 17822748
[TBL] [Abstract][Full Text] [Related]
10. A case of uterine cervical carcinosarcoma recurrence who obtained a clinically complete response by ifosfamide, doxorubicin and cisplatin.
Xu C; Nishi H; Isaka K
Eur J Gynaecol Oncol; 2011; 32(1):119-21. PubMed ID: 21446343
[TBL] [Abstract][Full Text] [Related]
11. Early-stage carcinosarcoma of the uterus: the significance of lymph node count.
Temkin SM; Hellmann M; Lee YC; Abulafia O
Int J Gynecol Cancer; 2007; 17(1):215-9. PubMed ID: 17291256
[TBL] [Abstract][Full Text] [Related]
12. Patterns of failure for conservatively managed surgical stage I uterine carcinosarcoma: implications for adjuvant therapy.
Leath CA; Numnum TM; Kendrick JE; Frederick PJ; Rocconi RP; Conner MG; Straughn JM
Int J Gynecol Cancer; 2009 Jul; 19(5):888-91. PubMed ID: 19574779
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of adjuvant pelvic radiation "sandwiched" between ifosfamide or ifosfamide plus cisplatin in women with uterine carcinosarcoma.
Einstein MH; Klobocista M; Hou JY; Lee S; Mutyala S; Mehta K; Reimers LL; Kuo DY; Huang GS; Goldberg GL
Gynecol Oncol; 2012 Jan; 124(1):26-30. PubMed ID: 22055846
[TBL] [Abstract][Full Text] [Related]
14. Gynecologic Cancer InterGroup (GCIG) consensus review for uterine and ovarian carcinosarcoma.
Berton-Rigaud D; Devouassoux-Shisheboran M; Ledermann JA; Leitao MM; Powell MA; Poveda A; Beale P; Glasspool RM; Creutzberg CL; Harter P; Kim JW; Reed NS; Ray-Coquard I
Int J Gynecol Cancer; 2014 Nov; 24(9 Suppl 3):S55-60. PubMed ID: 25341582
[TBL] [Abstract][Full Text] [Related]
15. Uterine cervical carcinosarcoma with heterologous mesenchymal component: a case report and review of the literature.
Kadota K; Haba R; Ishikawa M; Kushida Y; Katsuki N; Hayashi T; Miyai Y; Bando K; Shiota A; Hata T
Arch Gynecol Obstet; 2009 Nov; 280(5):839-43. PubMed ID: 19263060
[TBL] [Abstract][Full Text] [Related]
16. The role of cytoreductive surgery for newly diagnosed advanced-stage uterine carcinosarcoma.
Tanner EJ; Leitao MM; Garg K; Chi DS; Sonoda Y; Gardner GJ; Barakat RR; Jewell EL
Gynecol Oncol; 2011 Dec; 123(3):548-52. PubMed ID: 21945551
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy for Uterine Carcinosarcoma with Carboplatin, Ifosfamide and Mesna.
Dandamudi RK; Aslam S; Walji N; El-Modir A; Fernando I
Anticancer Res; 2015 Sep; 35(9):4841-7. PubMed ID: 26254376
[TBL] [Abstract][Full Text] [Related]
18. The management of patients with uterine sarcoma: a debated clinical challenge.
Gadducci A; Cosio S; Romanini A; Genazzani AR
Crit Rev Oncol Hematol; 2008 Feb; 65(2):129-42. PubMed ID: 17706430
[TBL] [Abstract][Full Text] [Related]
19. Carcinosarcoma of the uterus: A case report.
Adachi Y; Nonogaki H; Minamiguchi S; Li M; Ikehara S
Mol Clin Oncol; 2016 Apr; 4(4):571-573. PubMed ID: 27073665
[TBL] [Abstract][Full Text] [Related]
20. Uterine carcinosarcomas and grade 3 endometrioid cancers: evidence for distinct tumor behavior.
Bansal N; Herzog TJ; Seshan VE; Schiff PB; Burke WM; Cohen CJ; Wright JD
Obstet Gynecol; 2008 Jul; 112(1):64-70. PubMed ID: 18591309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
